Aragaki Masatoresearchmap個人ページ

Last Updated : 2018/07/03

Basic Information

Profile

Affiliation
Hokkaido University Hospital Clinical Research & Medical Innovation Center
Job TitleSpecially Appointed Assistant Professor 
Degree
E-mailaramasa1022hotmail.co.jp
URL
Research funding number

Research Areas

Biomolecular science / Biomolecular chemistry
Clinical surgery / Respiratory surgery
Display all
Research Areasclose
Biomolecular science / Biomolecular chemistry
Clinical surgery / Respiratory surgery

Research Activities

Papers

Anomalous V2 of the left pulmonary vein detected using three-dimensional computed tomography in a patient with lung cancer: A case report.
Aragaki M, Iimura Y, Yoshida Y, Hasegawa N
International journal of surgery case reports 37 208-210 2017
[Transmanubrial Osteomuscular-sparing Approach for Resection of Superior Mediastinal Schwannoma].
Aragaki M, Iimura Y, Sato N, Fukuda N, Miyazaki D, Umemoto K, Yoshida Y, Hasegawa N
Kyobu geka. The Japanese journal of thoracic surgery 69(9) 760-763 2016/08
[Mediastinal Mature Teratoma Necessitating Resection of Superior Vena Cava].
Aragaki M, Iimura Y, Hasegawa N, Kaga K
Kyobu geka. The Japanese journal of thoracic surgery 68(10) 845-849 2015/09
Paraneoplastic extralimbic encephalitis associated with thymoma: a case report.
Aragaki M, Iimura Y, Teramoto K, Sato N, Hirose K, Hasegawa N
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 21(4) 399-402 2015
A case of Castleman's disease with myasthenia gravis.
Ishikawa K, Kato T, Aragaki M, Ohbuchi T, Kimura S, Matsui Y, Kaji M
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20(Supplement) 585-588 2014
RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer.
Oshita H, Nishino R, Takano A, Fujitomo T, Aragaki M, Kato T, Akiyama H, Tsuchiya E, Kohno N, Nakamura Y, Daigo Y
Molecular cancer research : MCR 11(8) 937-951 2013/08
Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: differences according to histology and smoking status.
Kato T, Ishikawa K, Aragaki M, Sato M, Okamoto K, Ishibashi T, Oba K, Kaji M
Journal of surgical oncology 107(6) 619-624 2013/05
Endobronchial closure of a bronchopleural fistula using a fibrin glue-coated collagen patch and fibrin glue.
Ishikawa K, Kato T, Aragaki M, Hase R, Saikai T, Matsui Y, Kaji M
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 19(6) 423-427 2013
Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients.
Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, Kaji M
Journal of surgical oncology 106(4) 423-430 2012/09
Angiolymphatic invasion exerts a strong impact on surgical outcomes for stage I lung adenocarcinoma, but not non-adenocarcinoma.
Kato T, Ishikawa K, Aragaki M, Sato M, Okamoto K, Ishibashi T, Kaji M
Lung cancer (Amsterdam, Netherlands) 77(2) 394-400 2012/08
Display all
Papersclose
Anomalous V2 of the left pulmonary vein detected using three-dimensional computed tomography in a patient with lung cancer: A case report.
Aragaki M, Iimura Y, Yoshida Y, Hasegawa N
International journal of surgery case reports 37 208-210 2017
[Transmanubrial Osteomuscular-sparing Approach for Resection of Superior Mediastinal Schwannoma].
Aragaki M, Iimura Y, Sato N, Fukuda N, Miyazaki D, Umemoto K, Yoshida Y, Hasegawa N
Kyobu geka. The Japanese journal of thoracic surgery 69(9) 760-763 2016/08
[Mediastinal Mature Teratoma Necessitating Resection of Superior Vena Cava].
Aragaki M, Iimura Y, Hasegawa N, Kaga K
Kyobu geka. The Japanese journal of thoracic surgery 68(10) 845-849 2015/09
Paraneoplastic extralimbic encephalitis associated with thymoma: a case report.
Aragaki M, Iimura Y, Teramoto K, Sato N, Hirose K, Hasegawa N
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 21(4) 399-402 2015
A case of Castleman's disease with myasthenia gravis.
Ishikawa K, Kato T, Aragaki M, Ohbuchi T, Kimura S, Matsui Y, Kaji M
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20(Supplement) 585-588 2014
RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer.
Oshita H, Nishino R, Takano A, Fujitomo T, Aragaki M, Kato T, Akiyama H, Tsuchiya E, Kohno N, Nakamura Y, Daigo Y
Molecular cancer research : MCR 11(8) 937-951 2013/08
Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: differences according to histology and smoking status.
Kato T, Ishikawa K, Aragaki M, Sato M, Okamoto K, Ishibashi T, Oba K, Kaji M
Journal of surgical oncology 107(6) 619-624 2013/05
Endobronchial closure of a bronchopleural fistula using a fibrin glue-coated collagen patch and fibrin glue.
Ishikawa K, Kato T, Aragaki M, Hase R, Saikai T, Matsui Y, Kaji M
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 19(6) 423-427 2013
Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients.
Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, Kaji M
Journal of surgical oncology 106(4) 423-430 2012/09
Angiolymphatic invasion exerts a strong impact on surgical outcomes for stage I lung adenocarcinoma, but not non-adenocarcinoma.
Kato T, Ishikawa K, Aragaki M, Sato M, Okamoto K, Ishibashi T, Kaji M
Lung cancer (Amsterdam, Netherlands) 77(2) 394-400 2012/08
Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients.
Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, Kaji M
Lung cancer (Amsterdam, Netherlands) 75(1) 110-118 2012/01
Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients.
Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, Kondo S, Kaji M
Lung cancer (Amsterdam, Netherlands) 74(1) 124-131 2011/10
Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer.
Aragaki M, Takahashi K, Akiyama H, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y
Clinical cancer research : an official journal of the American Association for Cancer Research 17(18) 5889-5900 2011/09
Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.
Sato N, Yamabuki T, Takano A, Koinuma J, Aragaki M, Masuda K, Ishikawa N, Kohno N, Ito H, Miyamoto M, Nakayama H, Miyagi Y, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y
Cancer research 70(13) 5326-5336 2010/07

Top

  • HOME
  • Previous Page